Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cutaneous or Discoid Lupus Erythematosus Emily Rothstein, DVM, DACVD BASIC INFORMATION Description Cutaneous lupus erythematosus is an ulcerative skin disease that involves the hairless, “button” part of the nose of dogs and cats. In severe cases, the skin around the nose, lips, and parts of the mouth may be affected. Causes Discoid lupus is likely caused by a combination of genetic factors and the effects of sunlight on the skin, which may induce a destructive immune response. The condition occurs most often in the collie, Shetland sheepdog, German shepherd dog, and Siberian husky. The immune system attacks the bottom layer of the skin (epidermis) with secondary erosions and ulcerations. Clinical Signs Early lesions include redness and loss of pigment of the skin and nose. As lesions worsen, the cobblestone architecture of the tip of the nose is lost. Later, skin may become quite raw, and scabs can be seen. Diagnostic Tests The clinical appearance can suggest the diagnosis, but a biopsy is needed to absolutely determine the presence of this condition, since several other diseases create a similar appearance. Specialized examination of the biopsy specimens may be needed to determine the presence of an autoimmune reaction in which the immune system is attacking the skin cells. Other laboratory tests may be recommended prior to starting therapy to determine whether it is safe to start certain medications. TREATMENT AND FOLLOW-UP Treatment Options Avoiding exposure to the sun and using sunscreens are important measures to protect the skin from ultraviolet light. Topical therapy (applied directly to the skin) with steroids or immune-modulating drugs may be successful in mild cases. Systemic therapy with oral vitamin E, steroids, and other immune-suppressive drugs is indicated if topical therapy is ineffective and for severe cases. Numerous drug options are available for this disease, and some of them have potential side effects that require careful monitoring. Follow-up Care After treatment has been started, recheck visits are usually scheduled about every 2-4 weeks to evaluate the response to therapy. Once clinical remission has been achieved, the visits are often continued at 1-month intervals as the drug dosages are being tapered, and then every 6 months during maintenance therapy. If systemic therapy is used, laboratory tests are periodically needed to monitor for side effects from the medications and to make sure no secondary infections are starting. Prognosis This disease can usually be successfully controlled, but a cure is not expected. Prolonged treatment and monitoring are typically required, with periodic adjustment of medications and their dosages. If you have other questions or concerns about this, or other health topics, please call McFarland Animal Hospital 608-838-3400 Copyright © 2011 by Saunders, an imprint of Elsevier Inc. All rights reserved.